Anurekha G Hall
Overview
Explore the profile of Anurekha G Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steineck A, Chao K, Hall A, Jacoby E, Leahy A, Ligon J, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31516.
PMID: 39844726
Chimeric antigen receptor (CAR) T-cell therapy is a potentially life-saving treatment for children with relapsed/refractory B-cell hematologic malignancies, and remains an important investigational therapy for other childhood cancers. Yet, access...
2.
Auletta J, Holter-Chakrabarty J, Munshi P, Wall S, Khera N, Knutson J, et al.
Transplant Cell Ther
. 2024 Sep;
30(12):1124-1138.
PMID: 39277113
The Third Annual Workshop of the American Society for Transplantation and Cellular Therapy (ASTCT) and National Marrow Donor Program (NMDP) ACCESS Initiative occurred on July 23 and 24, 2024. Content...
3.
Judge Santacroce S, Beauchemin M, Pelletier W, Robles J, Ruiz J, Blazin L, et al.
Pediatr Blood Cancer
. 2024 Sep;
71(11):e31321.
PMID: 39238140
Background: Increasing representation in clinical trials is a priority for the National Cancer Institute and Children's Oncology Group (COG). Our survey of COG-affiliated institutions revealed that many sites have insufficient...
4.
Hall A, Duenas D, Voutsinas J, Wu Q, Lamble A, Gruber E, et al.
JNCI Cancer Spectr
. 2024 Jul;
8(4).
PMID: 39078720
Background: Receipt of chimeric antigen receptor T-cell (CAR-T) therapy at an institution different from the primary oncologist's institution is a complex, multistep process. Referral by oncologists plays an important role...
5.
Beauchemin M, Ortega M, Santacroce S, Robles J, Ruiz J, Hall A, et al.
JNCI Cancer Spectr
. 2024 Jun;
8(4).
PMID: 38889291
Background: Persons who speak languages other than English are underrepresented in clinical trials, likely in part because of inadequate multilevel resources. We conducted a survey of institutions affiliated with the...
6.
Hall A, Winestone L, Sullivan E, Wu Q, Lamble A, Walters M, et al.
Transplant Cell Ther
. 2023 Mar;
29(6):356.e1-356.e7.
PMID: 36966871
Chimeric antigen receptor T cell (CAR-T) therapy is a promising approach to improve survival for children and adults with relapsed/refractory (r/r) B cell acute lymphoblastic leukemia (B-ALL), but these clinical...
7.
Hall A, Syrjala K, Ketterl T, Ganz P, Jacobs L, Palmer S, et al.
J Adolesc Young Adult Oncol
. 2023 Feb;
12(5):701-709.
PMID: 36779982
The majority of adolescent and young adult (AYA) cancer survivors do not receive recommended health care surveillance after therapy. We used cross-sectional survey data to evaluate the impact of income,...
8.
Taylor M, Steineck A, Lahijani S, Hall A, Jim H, Phelan R, et al.
Transplant Cell Ther
. 2022 Oct;
29(1):19-26.
PMID: 36208728
Chimeric antigen receptor (CAR) T-cell therapy has demonstrated remarkable clinical responses in hematologic malignancies. Recent advances in CAR T-cell therapy have expanded its application into other populations including older patients...
9.
Desai A, Applebaum M, Karrison T, Oppong A, Yuan C, Berg K, et al.
Cancer
. 2022 Jun;
128(15):2967-2977.
PMID: 35665495
Background: High-risk neuroblastoma patients with end-induction residual disease commonly receive post-induction therapy in an effort to increase survival by improving the response before autologous stem cell transplantation (ASCT). The authors...
10.
Durani U, Major A, Velazquez A, May J, Nelson M, Zheng Z, et al.
JCO Oncol Pract
. 2022 Jan;
18(4):e586-e599.
PMID: 34990292
Purpose: Graduate medical and research training has drastically changed during the COVID-19 pandemic, with widespread implementation of virtual learning, redeployment from core rotations to the care of patients with COVID-19,...